Latest Cancer News

The US Food and Drug Administration has Expanded the Approval of the Precision Cancer Medicine Keytruda for Treatment of Gastric Cancer (09-25-2017)
Keytruda (Pembrolizumab) is now indicated for patients with recurrent locally advanced or metastatic gastric or gastro-esophogeal junction adenocarcinoma. Patients eligible for keytruda therapy under this... Continue Reading

FDA Adds Two Roche Multiple Myeloma Studies Evaluating Checkpoint Inhibitors to List of Partial Clinical Holds Over Safety Concerns (09-25-2017)
Alarmed that an imbalance in deaths among patients taking a combination of Keytruda (pembrolizumab) with Celgene’s Pomalyst and Revlimid could represent a threat in that whole class of checkpoint comboinations,... Continue Reading

Alecensa Appears Superior to Xalkori in ALK positive NSCLC Involving the Brain (09-21-2017)
The results from two separate clinical studies comparing Alecensa® (alectinib) to Xalkori (crizotinib) presented at the European Society for Medical Oncology in Madrid demonstrate that Alecensa®  s... Continue Reading

More Cancer News

Locations

Louisiana Hematology Oncology Associates
Main Office:
4950 Essen Lane, Ste 500
Baton Rouge, LA 70809
Phone: (225) 767-1311
Fax: (225) 767-1335
Louisiana Hematology Oncology Associates
Satellite Offices:
Woman’s Hospital
9000 Airline Hwy.
Suite 290
Baton Rouge, LA 70815
Phone: (225)767-1311
Gonzales
1104 W. Hwy 30
Gonzales, LA 70737
Phone: (225) 215-1547

Zachary
4753 W. Park Dr.
Zachary, LA 70809
Phone: (225) 658-8779